Synchronous gastrointestinal stromal tumour and neuroendocrine tumour in a patient with neurofibromatosis type 1: a rare clinical association

Authors

  • Ashwini C. Hiremath Institute of Surgical Gastroenterology and Liver Transplantation, Stanley Medical College, Tamil Nadu, Chennai, India
  • Jeswanth Satyanesan Institute of Surgical Gastroenterology and Liver Transplantation, Stanley Medical College, Tamil Nadu, Chennai, India
  • Anand Lakshmanan Institute of Surgical Gastroenterology and Liver Transplantation, Stanley Medical College, Tamil Nadu, Chennai, India
  • Senthil Kumar Institute of Surgical Gastroenterology and Liver Transplantation, Stanley Medical College, Tamil Nadu, Chennai, India

DOI:

https://doi.org/10.18203/2349-2902.isj20262480

Keywords:

Neurofibromatosis type 1, GIST, Neuroendocrine tumour

Abstract

Type 1 Neurofibromatosis (NF1) is an autosomal dominant disorder caused by germline mutation of the NF1 gene. While it typically manifests as multiple cutaneous neurofibromas and café-au-lait macules, patients also have an inherent predisposition to neoplasms arising from neural crest–derived tissues and the gastrointestinal tract. GISTs are relatively well-recognized in NF1, whereas neuroendocrine tumours (NET) are uncommon. The synchronous occurrence of both NET and GIST in an NF1 patient is exceedingly rare. We present a 53-year-old female with known NF1 who developed synchronous small-bowel GIST and pancreatic NET. The patient presented with intermittent jaundice. Imaging suggestive of periampullary carcinoma. During Whipple’s procedure, lesions suggestive of periampullary carcinoma and small bowel GIST were identified. Both tumours were resected. Histopathology confirmed high grade spindle-cell GIST and well-differentiated NET. The postoperative course was uneventful.  NF1-associated GISTs are not uncommon, but coexistent NETs are rare and easily overlooked. This case underscores the need for heightened vigilance and a broadened differential diagnosis in NF1 patients presenting with gastrointestinal symptoms, as synchronous multifocal tumours may be missed without careful evaluation.

References

Hirbe AC, Gutmann DH. Neurofibromatosis type 1: a multidisciplinary approach to care. Lancet Neurol. 2014;13:834-43.

Basile U, Cavallaro G, Polistena A, Giustini S, Orlando G, Cotesta D, et al. Gastrointestinal and Retroperitoneal Manifestations of Type 1 Neurofibromatosis. J Gastrointest Surg. 2010;14(1):186-94.

Agaimy A, Vassos N, Croner RS. Gastrointestinal manifestations of neurofibromatosis type 1 (Recklinghausen’s disease): clinicopathological spectrum with pathogenetic considerations. Int J Clin Exp Pathol. 2012;5:852-62.

Anastasaki C, Orozco P, Gutmann DH. RAS and beyond: the many faces of the neurofibromatosis type 1 protein. Dis Model Mech. 2022;15:dmm049362.

Nishida T, Tsujimoto M, Takahashi T, Hirota S, Blay JY, Wataya-Kaneda M. Gastrointestinal stromal tumors in Japanese patients with neurofibromatosis type I. J Gastroenterol. 2016;51(6):571-8.

Salvi PF, Lorenzon L, Caterino S, Antolino L, Antonelli MS, Balducci G. Gastrointestinal Stromal Tumors Associated with Neurofibromatosis 1: A Single Centre Experience and Systematic Review of the Literature Including 252 Cases. Int J Surg Oncol. 2013;2013:398570.

Yao MQ, Jiang YP, Yi BH, Yang Y, Sun DZ, Fan JX. Neurofibromatosis type 1 with multiple gastrointestinal stromal tumors: A case report. World J Clin Cases. 2023;11(10):2336-42.

Lee JL, Kim JY, Ryu MH, Kang HJ, Chang HM, Kim TW, et al. Response to Imatinib in KIT- and PDGFRA-Wild Type Gastrointestinal Stromal Associated with Neurofibromatosis Type 1. Dig Dis Sci. 2006;51(6):1043-6.

9. Rosai J. The origin of neuroendocrine tumors and the neural crest saga. Mod Pathol. 2011;24:S53-7.

Larizza L, Gervasini C, Natacci F, Riva L, Dalprà G, Griscioli GA. Developmental Abnormalities and Cancer Predisposition in Neurofibromatosis Type 1. Curr Mol Med. 2009;9(5):634-53.

Mantalovas S, Karakousis VA, Sevva C, Roulia P, Savvakis S, Anthimidis G, et al. Multifocal Gastrointestinal Stromal Tumors (GISTs) of the Small Intestine in Patients with Neurofibromatosis Type 1 (NF-1): Meta-Analysis and Systematic Review of the Literature. Cancers (Basel). 2025;17(12):1934.

Downloads

Published

2026-07-28

How to Cite

Hiremath, A. C., Satyanesan, J., Lakshmanan, A., & Kumar, S. (2026). Synchronous gastrointestinal stromal tumour and neuroendocrine tumour in a patient with neurofibromatosis type 1: a rare clinical association . International Surgery Journal, 13(8), 1509–1512. https://doi.org/10.18203/2349-2902.isj20262480

Issue

Section

Case Reports